^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

oritinib (SH-1028)

i
Other names: SH 1028, SH-1028
Company:
Nanjing Sanhome Pharma
Drug class:
EGFR inhibitor, Tyrosine kinase inhibitor
Related drugs:
2years
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
|
Tagrisso (osimertinib) • Ivesa (furmonertinib) • oritinib (SH-1028)